Loading...
XHKG
2666
Market cap1.16bUSD
Oct 09, Last price  
4.56HKD
1D
1.11%
1Q
-0.22%
Jan 2017
-28.86%
IPO
-34.01%
Name

Genertec Universal Medical Group Co Ltd

Chart & performance

D1W1MN
XHKG:2666 chart
P/E
3.55
P/S
0.54
EPS
1.10
Div yield, %
7.76%
Shrs. gr., 5y
3.24%
Rev. gr., 5y
12.02%
Revenues
14.54b
+6.41%
984,020,0001,556,761,0002,195,202,0002,708,715,0003,423,980,0004,295,013,0006,746,812,0008,243,234,0009,566,906,00011,565,809,00013,650,203,00013,663,485,00014,538,848,000
Net income
2.21b
+4.99%
312,738,000456,638,000658,526,000872,310,0001,148,658,0001,352,173,0001,588,336,0001,747,137,0001,947,730,0001,959,820,0002,110,337,0002,103,957,0002,208,951,000
CFO
4.05b
+255.56%
-4,119,417,000-4,110,715,000-4,452,389,000-2,381,645,000-5,072,151,000-5,728,645,000-1,823,905,000-971,721,000-1,400,570,0002,057,196,0004,993,965,0001,138,308,0004,047,342,228
Dividend
Jun 26, 20260.36 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Genertec Universal Medical Group Company Limited, founded in 1984 and based in Beijing, China, provides extensive financing and advisory services across the People's Republic of China, alongside operating a significant healthcare business. The company's operations are segmented into two primary divisions. The Finance and Advisory segment delivers a range of services including direct finance leasing, sale-and-leaseback arrangements, factoring, operating leases, and various advisory offerings. Meanwhile, its Hospital Group segment focuses on providing medical care, managing hospitals and healthcare facilities, and conducting import, export, and general trading of medical-related goods. Beyond these core areas, Genertec Universal Medical also engages in medical technology development, hospital digitalization, construction, and management services, as well as property management and medical consulting. The company serves a diverse clientele, encompassing patients, hospitals, medical equipment suppliers, and other public sector organizations. In July 2018, the company adopted its current name, having previously operated as Universal Medical Financial & Technical Advisory Services Company Limited.

Key people

Shisu Chen
Executive Chairman of the Board · since 2024
Wenbing Wang
Chief Executive Officer, Executive Director · since 2021
Lin Wang
Executive Director · since 2023
Wai Kam Ng
Company Secretary · since 2019
Tong Chaoyin
Non-Executive Director · since 2021
Youjie Huang
Non-Executive Director · since 2025
Chunhai Lin
Non-Executive Director · since 2025
Wanming Ma
Non-Executive Director · since 2025
Non-Executive Independent Director · since 2022
Non-Executive Independent Director · since 2015
Non-Executive Independent Director · since 2015
Zhiming Xu
Non-Executive Independent Director · since 2022
IPO date
Jul 08, 2015
Employees
20,048
Domiciled in
CN
Incorporated in
HK
Legal address
RM 702, Fairmont House
8 Cotton Tree Drive
Central
Hong Kong 999077
HK
Headquarters
9th&10th floor, West Wing of Sichuan Building
No.1, Fuwai Street
Xicheng District
Beijing 065001
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT